Additionally, Chen et al. reported increased expression of GFAT in NSCLC cell lines and tissues and showed that inhibiting GFAT activity or knocking down GFAT impairs cell proliferation and enhances cytotoxicity when combined with cisplatin treatment [57]. The gene discussed is GFPT2; the disease is non-small cell lung carcinoma.